Asuragen’s molecular assays are designed to provide streamlined workflow and ease of use and is comprised of two product portfolios; Genetics and Oncology. The genetics portfolio includes assays aiding in the detection of the FMR1 and C9orf72 gene, while the Oncology assays use molecular methods ranging from qPCR to NGS to assist our understanding of cancer.
Devyser are specialists when it comes to complex DNA testing within hereditary diseases and oncology with products used to guide targeted cancer therapies and enable rapid prenatal diagnostics. Included in their portfolio is the BRCA NGS kit for detection of BRCA1 and BRCA2 in germline and somatic samples as well as the Fetal RHD kit used to determine fetal RHD status from maternal plasma.
Biocartis provides fully integrated and broadly applicable molecular diagnostics. The Idylla is Biocartis’ fully automated, real-time PCR-based molecular diagnostics system which provides fast access to highly reliable clinical molecular diagnostic information. The Idylla can detect BRAF V600E, E2, D, K, R and M mutations within 90 minutes.
Invivoscribe provides a comprehensive selection of PCR-based gene rearrangement, chromosome translocation, and gene mutation Research Use Only testing reagents and controls. They also provide CE-marked in vitro diagnostic products that are used to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative diseases.
Nikon is the world leader in microscope-based optical & imaging technologies. They are focused & committed to accelerating clinical and diagnostic imaging innovation to improve healthcare. Nikon’s upright microscopes offer a wide range of objectives and uniform illumination, providing bright images to the edge of the field of view and faithful colour reproduction of the specimen. In addition, they are designed with intuitive and comfortable operability that reduces fatigue even during long-term observation.
OriGen Biomedical manufacture an innovative range of speciality bags and reagents for cell culture and cryopreservation including CAR-T therapy.
ZytoVision develop and produce innovative in vitro diagnostic products, primarily for tumour diagnosis, based on the technique of in situ hybridization using FISH and CISH techniques.
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
[…]
WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.
The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
[…]
Abacus dx are thrilled to announce ZytoVision* received their In Vitro Diagnostics Regulation (IVDR) certification for its selected product portfolio.
[…]
Asuragen’s Precision Oncology Solutions.
Revolutionising Precision Oncology with QuantideX®: Where Sensitivity Meets Scalability
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Within 150 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge
[…]